Updates are available Correction dated 2021-06-22
Click to view Correction: https://doi.org/10.1038/s41380-021-01192-0
-
Authors
Rogdaki, Maria https://orcid.org/0000-0003-2685-1789
Devroye, Céline
Ciampoli, Mariasole
Veronese, Mattia https://orcid.org/0000-0003-3562-0683
Ashok, Abhishekh H. https://orcid.org/0000-0003-3636-7253
McCutcheon, Robert A. https://orcid.org/0000-0003-1102-2566
Jauhar, Sameer https://orcid.org/0000-0002-3878-3659
Bonoldi, Ilaria
Gudbrandsen, Maria https://orcid.org/0000-0002-0464-2065
Daly, Eileen https://orcid.org/0000-0003-3625-3467
van Amelsvoort, Therese
Van Den Bree, Marianne https://orcid.org/0000-0002-4426-3254
Owen, Michael J. https://orcid.org/0000-0003-4798-0862
Turkheimer, Federico https://orcid.org/0000-0002-3766-3815
Papaleo, Francesco https://orcid.org/0000-0002-6326-0657
Howes, Oliver D.
-
Funding
Funding for this research was provided by:
Wellcome Trust (200102/Z/15/Z)
RCUK | Medical Research Council (MR/N022572/1)
RCUK | Medical Research Council (MR/L011166/1) 2315/1)
RCUK | Medical Research Council (MR/N022572/1)
RCUK | Medical Research Council (MR/L011166/1) 2315/1)
RCUK | Medical Research Council (MC-A656-5QD30)
Health and Care Research Wales (507556)
Health and Care Research Wales (507556)
Istituto Italiano di Tecnologia
Brain and Behavior Research Foundation (23234)
South London and Maudsley NHS Foundation Trust (666)
- License Information
-
More Information
Article History
Received: 14 September 2020
Revised: 10 March 2021
Accepted: 8 April 2021
First Online: 12 May 2021
Change Date: 22 June 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41380-021-01192-0
Compliance with ethical standards
:
: MR, CD, MC, AA, RAM, SJ, IB, MG, ED, TvA, FT and FP declare no competing interests. ODH has received investigator-initiated research funding from and/or participated in advisory/speaker meetings organized by Angellini, Astra-Zeneca, Autifony, Biogen, BMS, Eli Lilly, Heptares, Jansenn, Lundbeck, Lyden-Delta, Otsuka, Servier, Sunovion, Rand and Roche. Neither ODH nor his family has been employed by or has holdings/a financial stake in any biomedical company. MV is consultant for GSK but no competing interests with this work exists. MJO and MVDB report grants from Takeda Pharmaceuticals outside of the submitted work.
